Two types of copd

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

Types of Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD) is a complex and heterogeneous condition, characterized by persistent respiratory symptoms and airflow limitation. Recent research has identified distinct subtypes of COPD, each with unique clinical features and implications for treatment and prognosis.

Clinically Relevant COPD Subtypes

Severe Respiratory COPD

One of the identified subtypes is "severe respiratory COPD," characterized by significant airflow limitation and poor performance in respiratory domains. Patients in this group exhibit a post-bronchodilator forced expiratory volume in 1 second (FEV1) of approximately 38% predicted. This subtype is associated with more frequent hospitalizations due to COPD exacerbations and higher all-cause mortality rates compared to other subtypes .

Moderate Respiratory COPD

Another subtype is "moderate respiratory COPD," which shows milder airflow limitation with an FEV1 of around 63% predicted. Patients in this group generally have better respiratory function and fewer hospitalizations compared to those with severe respiratory COPD .

Systemic COPD

The third subtype, "systemic COPD," combines milder airflow limitation (FEV1 around 58% predicted) with a high prevalence of obesity, cardiovascular disorders, diabetes, and systemic inflammation. This group is more prone to hospital admissions due to cardiovascular diseases rather than respiratory issues .

Phenotypic Variations in COPD

Emphysematous Phenotype

The emphysematous phenotype, also known as type 1 COPD, is characterized by lower FEV1 values and greater levels of dyspnea. This phenotype represents about 43.2% of COPD patients and is associated with worse pulmonary function compared to other phenotypes .

Chronic Bronchitic Phenotype

The chronic bronchitic phenotype, or type 2 COPD, accounts for 44.7% of COPD patients. These patients often have a higher prevalence of cardiovascular comorbidities and sleep apnea syndrome. Despite these comorbidities, there are no significant differences in the use of hospital health care resources compared to other phenotypes .

COPD-Asthma Overlap

The COPD-asthma overlap, or type 3 COPD, presents mixed characteristics of both COPD and asthma. This phenotype is less common, representing about 12.1% of COPD patients. Patients with this phenotype often show a favorable response to corticosteroids, similar to asthma patients, and have increased airway wall eosinophil counts and bronchodilator reversibility 23.

Conclusion

COPD is not a uniform disease but rather a collection of subtypes with distinct clinical features and comorbidities. Understanding these subtypes—severe respiratory COPD, moderate respiratory COPD, systemic COPD, emphysematous phenotype, chronic bronchitic phenotype, and COPD-asthma overlap—can help tailor treatment strategies and improve patient outcomes. Identifying and validating these subtypes is crucial for advancing COPD management and providing personalized care.

Sources and full results

Most relevant research papers on this topic

Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes

Three distinct COPD subtypes were identified and validated in patients at their first hospitalization: severe respiratory COPD, moderate respiratory COPD, and systemic COPD.

Observational StudyRigorous JournalHighly Cited

2010·

341citations

·J. Garcia-Aymerich et al.

Asthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease.

Asthma-associated gene signatures are increased in COPD and associated with increased severity and "asthma-like" features, suggesting Th2 inflammation is important in a subset of COPD not identified by clinical history of asthma.

RCTLarge Human TrialHighly Cited

2015·

251citations

·S. Christenson et al.

Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD).

Emphysematous COPD patients have worse pulmonary function and greater dyspnea, while chronic bronchitic COPD patients have greater comorbidity, requiring specific strategies for these subgroups.

Observational StudyHighly Cited

2013·

115citations

·J. L. Izquierdo-Alonso et al.

Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook.

Targeting type 2 inflammation and epithelial alarmins in COPD may help address unmet treatment needs and improve lung function.

2023·

18citations

·K. Rabe et al.

"Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art."

Phenotypic approach to COPD management has significantly impacted everyday practice, but more large-scale, well-designed trials are needed for precision medicine and personalized treatment.

Highly Cited

2019·

78citations

·A. Corlateanu et al.

Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

COPD patients have a higher risk of developing cardiovascular diseases and major risk factors, emphasizing the need for strategies to screen for and reduce these risks.

Meta-AnalysisRigorous JournalHighly Cited

2015·

520citations

·Wenjia Chen et al.

Does COPD Originate from Different Cell Types?

Different cell types in the lung may initiate COPD pathogenesis, with new technologies and approaches advancing our understanding of the disease's pathophysiology and clinical heterogeneity.

2023·

4citations

·Y. Tesfaigzi et al.

Asthma and COPD: Similarities and Differences in the Pathophysiology, Diagnosis and Therapy.

Asthma and COPD share similar symptoms, but asthmatics have a dry, nighttime cough caused by allergies, while COPD is caused by smoking, and both diseases have limited life expectancy.

Systematic Review

2016·

30citations

·J. Yayan et al.

Proportional classifications of COPD phenotypes

This study provides proportional classifications of COPD phenotypic subgroups, aiding in further research into the pathogenesis and treatment of this heterogeneous disorder.

Observational StudyHighly Cited

2008·

238citations

·S. Marsh et al.

TH17 cells in asthma and COPD.

TH17 cells may play a role in severe, steroid-insensitive asthma and COPD by regulating neutrophilic and macrophage inflammation in the lung.

Highly Cited

2010·

365citations

·J. Alcorn et al.

Try another search

zinc hair loss

primary teeth letters

ras inhibitor drugs

how is chemotherapy administered

can chf be reversed

max dose metformin er